Our research has supported the manufacturing and quality control process of Qualicaps® capsules specifically designed for use in dry powder inhalers.

Working with Qualicaps®, a global market leader in the field of inhalation capsules, Professor James Birchall and Dr Sion Coulman from Cardiff’s School of Pharmacy and Pharmaceutical Sciences developed a test to successfully evaluate the puncture performance of capsules used within dry powder inhalers. Our research has informed Qualicaps®’ manufacturing processes, has helped to dramatically increase sales of their premium products, and enabled the company to enter new markets. In turn, these capsules are being used in dry powder inhalers prescribed to millions of patients with chronic lung disease worldwide.

Informing product development, supporting company growth and improving capsule performance for patients

The Quality Control Team at Qualicaps® used findings from our capsule performance test to enhance their products. Our findings  also influenced Qualicaps®' new investment into the research and development of their inhalation products.

In addition, our research has steered Qualicaps®' marketing and sales strategy to support the company's growth. For example, Qualicaps® continues to use our data to present at major international conferences and cites our findings in its marketing materials to attract new business.